Fingerprint
Dive into the research topics of 'Ruxolitinib is manageable in patients with myelofibrosis and severe thrombocytopenia: a report on 12 Danish patients'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ruxolitinib is manageable in patients with myelofibrosis and severe thrombocytopenia: a report on 12 Danish patients
Mads Emil Bjørn, Morten Orebo Holmström, Hans Carl Hasselbalch
16
Citations
(Scopus)